Safety and Efficacy of 0.05% and 0.1% RGN-259 for Subjects with Dry Eye Syndrome (DES): ARISE I
Year: 2017
Type: article
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,850
OpenAlex ID: W2750106543
